CERo Therapeutics Holdings, Inc. CERO
Set alert
0.00 USD 0.00 0.00%
As of Nov 2, 12:14 PM ET
0.0032 Day range 0.004
0.003 52-week range 0.209
- YTD
- -94.03%
- 1 year
- -95.79%
- Open
- 0.004
- Prev close
- 0.004
- Mkt cap
- 286.52K
- Vol
- 26.50K
- Avg vol
- 629.85K
- EPS
- 40.34
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0032
- High
- 0.004
- Forward P/E
- 0.00
- Beta
- -0.46
- Short ratio
- 0.29
- Inst. own
- 5.08%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.12674
- 200-d avg
- 0.62712
- 1y target
- 0.00
Ownership
Held by insiders 55.42%
Held by institutions 5.08%
Float held by institutions 11.39%
Institutions 21
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Arch Venture Management, Llc | 0.96% | 1,444,296 | 72.94K | Sep 29, 2024 |
| Avantax Planning Partners, Inc. | 0.91% | 1,361,130 | 68.74K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.10% | 157,445 | 7.95K | Sep 29, 2024 |
| Selkirk Management Llc | 0.08% | 121,040 | 6.11K | Sep 29, 2024 |
| HRT Financial LP | 0.05% | 79,562 | 4.02K | Sep 29, 2024 |
| Fifth Lane Capital, LP | 0.05% | 76,593 | 3.87K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.10% | 144,145 | 7.28K | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ATWOOD BRIAN G | Director | Conversion of Exercise of derivative security | Sep 24, 2024 | 0 |
| EHRLICH CHRISTOPHER B | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 24, 2024 | 5,795,410 |
| LAPORTE KATHLEEN D | Director | Conversion of Exercise of derivative security | Sep 24, 2024 | 0 |
| SLOAN STUART M | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 24, 2024 | 0 |
| YK BIOVENTURES OPPORTUNITIES GP I, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 12, 2024 | 0 |